Spots Global Cancer Trial Database for Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
Official Title: Controlled Clinical Trial to Evaluate the Safety and Efficacy of Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
Study ID: NCT04469699
Conditions
Study Description
Brief Summary: In this multicenter, randomized, non-blinded trial the efficacy and safety of stereotactical photodynamic therapy with 5-aminolevulinic acid will be investigated in 106 patients with recurrent glioblastoma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Medizinische Fakultät Carl Gustav Carus, Klinik und Poliklinik für Neurochirurgie, Dresden, , Germany
Universitätsklinikum Düsseldorf, Klinik für Neurochirurgie, Abteilung Funktionelle NC & Stereotaxie, Düsseldorf, , Germany
Universitätsklinikum Essen, Klinik für Neurochirurgie und Wirbelsäulenchirurgie, Essen, , Germany
LMU München, Campus Großhadern, Neurochirurgische Klinik und Poliklinik, München, , Germany
Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie, Münster, , Germany
Contact Details
Name: Walter Stummer, Univ.-Prof. Dr. med.
Affiliation: University Hospital Muenster, Klinik und Poliklinik für Neurochirurgie
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
